Ticker
FENCCompany Name
FENNEC PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 18.7M | 2.22 | $ 8.41M |
3/31/2025 | $ 22.68M | 2.71 | $ 8.37M |
12/31/2024 | $ 26.63M | 3.85 | $ 6.92M |
9/30/2024 | $ 40.32M | 5.42 | $ 7.43M |
6/30/2024 | $ 43.05M | 5.56 | $ 7.75M |
3/31/2024 | $ 51.18M | 5.2 | $ 9.84M |
12/31/2023 | $ 13.27M | 1.76 | $ 7.55M |
9/30/2023 | $ 12.4M | 3.17 | $ 3.91M |
6/30/2023 | $ 14.96M | 3.96 | $ 3.78M |
3/31/2023 | $ 18.39M | 4.57 | $ 4.02M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for FENNEC PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 33.17M ] / LiabilitesC [ $ 2.88M ]
(=) Cash Ratio [ 11.5 ]
Minimum
Dec 31, 2023
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |